Johnson - search results

For some time, there have been serious questions about the ROCKET-AF trial, the clinical study of the anti-coagulant medication Xarelto (rivaroxaban), prescribed for patients...

As the number of Xarelto lawsuits approaches 2,000 and the drug’s connection to fatal bleeding becomes more widely known, manufacturer Janssen Pharmaceutica is pulling...

Rivaroxaban, better known as Xarelto®, has been associated with hundreds of adverse events involving fatal and near-fatal hemorrhaging since it received FDA approval in...

The laproscopic power morcellator is just the latest in a long line of medical devices that have wound up doing far more harm than...

According to data from the U.S. Centers for Medicare and Medicaid, in 2014 Johnson & Johnson spent nearly $20 million on payments and various...

DePuy’s parent company, Johnson & Johnson, has announced that it will enter into a $2.475 billion DePuy hip settlement agreement with plaintiffs in MDL...